<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>pharmacology and toxicology</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>pharmacology and toxicology | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="Pharmacogenomics Guided Spaceflight: the intersection between space-flown drugs and space genes
Authors: Nelson, T. M.; Rose, J. K.; Walter, C. E.; Cervantes-Navarro, G. L.; Schmidt, C. M.; Lin, R.; Alexander, E.; Zheng, J. T.; Glicksberg, B. S.; Schmidt, J. C.; Overbey, E.; Rana, B.; Patel, H.; Schmidt, M. A.; Mason, C. E.
Score: 11.0, Published: 2024-01-20 DOI: 10.1101/2024.01.16.575951
Ten years ago, it was predicted that the multi-omics revolution would also revolutionize space pharmacogenomics.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/pharmacology-and-toxicology/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="pharmacology and toxicology" />
<meta property="og:description" content="Pharmacogenomics Guided Spaceflight: the intersection between space-flown drugs and space genes
Authors: Nelson, T. M.; Rose, J. K.; Walter, C. E.; Cervantes-Navarro, G. L.; Schmidt, C. M.; Lin, R.; Alexander, E.; Zheng, J. T.; Glicksberg, B. S.; Schmidt, J. C.; Overbey, E.; Rana, B.; Patel, H.; Schmidt, M. A.; Mason, C. E.
Score: 11.0, Published: 2024-01-20 DOI: 10.1101/2024.01.16.575951
Ten years ago, it was predicted that the multi-omics revolution would also revolutionize space pharmacogenomics." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/pharmacology-and-toxicology/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2024-01-28T10:37:59+00:00" />
<meta property="article:modified_time" content="2024-01-28T10:37:59+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="pharmacology and toxicology"/>
<meta name="twitter:description" content="Pharmacogenomics Guided Spaceflight: the intersection between space-flown drugs and space genes
Authors: Nelson, T. M.; Rose, J. K.; Walter, C. E.; Cervantes-Navarro, G. L.; Schmidt, C. M.; Lin, R.; Alexander, E.; Zheng, J. T.; Glicksberg, B. S.; Schmidt, J. C.; Overbey, E.; Rana, B.; Patel, H.; Schmidt, M. A.; Mason, C. E.
Score: 11.0, Published: 2024-01-20 DOI: 10.1101/2024.01.16.575951
Ten years ago, it was predicted that the multi-omics revolution would also revolutionize space pharmacogenomics."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "pharmacology and toxicology",
      "item": "https://trxiv.yorks0n.com/posts/pharmacology-and-toxicology/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "pharmacology and toxicology",
  "name": "pharmacology and toxicology",
  "description": "Pharmacogenomics Guided Spaceflight: the intersection between space-flown drugs and space genes\nAuthors: Nelson, T. M.; Rose, J. K.; Walter, C. E.; Cervantes-Navarro, G. L.; Schmidt, C. M.; Lin, R.; Alexander, E.; Zheng, J. T.; Glicksberg, B. S.; Schmidt, J. C.; Overbey, E.; Rana, B.; Patel, H.; Schmidt, M. A.; Mason, C. E.\nScore: 11.0, Published: 2024-01-20 DOI: 10.1101/2024.01.16.575951\nTen years ago, it was predicted that the multi-omics revolution would also revolutionize space pharmacogenomics.",
  "keywords": [
    
  ],
  "articleBody": " Pharmacogenomics Guided Spaceflight: the intersection between space-flown drugs and space genes\nAuthors: Nelson, T. M.; Rose, J. K.; Walter, C. E.; Cervantes-Navarro, G. L.; Schmidt, C. M.; Lin, R.; Alexander, E.; Zheng, J. T.; Glicksberg, B. S.; Schmidt, J. C.; Overbey, E.; Rana, B.; Patel, H.; Schmidt, M. A.; Mason, C. E.\nScore: 11.0, Published: 2024-01-20 DOI: 10.1101/2024.01.16.575951\nTen years ago, it was predicted that the multi-omics revolution would also revolutionize space pharmacogenomics. Current barriers related to the findable, accessible, interoperable, and reproducible use of space-flown pharmaceutical data have contributed to a lack of progress beyond application of earth-based principles. To directly tackle these challenges, we have produced a novel database of all the drugs flown into space, compiled from publicly available ontological and spaceflight-related datasets, to exemplify analyses for describing significant spaceflight-related targets. By focusing on mechanisms perturbed by spaceflight, we have provided a novel avenue for identifying the most relevant changes within the drug absorption, distribution, metabolism, and excretion pathways. We suggest a set of space genes, by necessity limited to available tissue types, that can be expanded and modified based on future tissue-specific and mechanistic-specific high-throughput assays. In sum, we provide the justification and a definitive starting point for pharmacogenomics guided spaceflight as a foundation of precision medicine, which will enable long-term human habitation of the Moon, Mars, and beyond. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=147 SRC=\"FIGDIR/small/575951v1_ufig1.gif\" ALT=\"Figure 1\"\u003e View larger version (27K): org.highwire.dtl.DTLVardef@ac3a07org.highwire.dtl.DTLVardef@115e07corg.highwire.dtl.DTLVardef@1450e46org.highwire.dtl.DTLVardef@ac1757_HPS_FORMAT_FIGEXP M_FIG C_FIG\nLarge library docking for cannabinoid-1 receptor agonists with reduced side effects\nAuthors: Tummino, T. A.; Iliopoulos-Tsoutsouvas, C.; Braz, J. M.; O'Brien, E. S.; Stein, R. M.; Craik, V.; Tran, N. K.; Ganapathy, S.; Liu, F.; Shiimura, Y.; Tong, F.; Ho, T. C.; Radchenko, D. S.; Moroz, Y. S.; Rosado, S. R.; Bhardwaj, K.; Benitez, J.; Liu, Y.; Kandasamy, H.; Normand, C.; Semache, M.; Sabbagh, L.; Glenn, I.; Irwin, J. J.; Kumar, K. K.; Makriyannis, A.; Basbaum, A. I.; Shoichet, B. K.\nScore: 12.2, Published: 2024-01-23 DOI: 10.1101/2023.02.27.530254\nLarge library docking can reveal unexpected chemotypes that complement the structures of biological targets. Seeking new agonists for the cannabinoid-1 receptor (CB1R), we docked 74 million tangible molecules, prioritizing 46 high ranking ones for de novo synthesis and testing. Nine were active by radioligand competition, a 20% hit-rate. Structure-based optimization of one of the most potent of these (Ki = 0.7 {micro}M) led to 4042, a 1.9 nM ligand and a full CB1R agonist. A cryo-EM structure of the purified enantiomer of 4042 ( 1350) in complex with CB1R-Gi1 confirmed its docked pose. The new agonist was strongly analgesic, with generally a 5-10-fold therapeutic window over sedation and catalepsy and no observable conditioned place preference. These findings suggest that new cannabinoid chemotypes may disentangle characteristic cannabinoid side-effects from their analgesia, supporting the further development of cannabinoids as pain therapeutics.\nThe contribution of neutrophils to bacteriophage clearance and pharmacokinetics in vivo\nAuthors: Echterhof, A.; Dharmaraj, T.; McBride, R.; Berry, J. D.; Hopkins, M.; Selvakumar, H.; Lin, K.-Y.; Chia, L.; Shen, C.-C.; Lioa, W.; Lee, P.; Yeh, T.; Suh, G.; Blankenberg, F. G.; Frymoyer, A.; Bollyky, P.\nScore: 1.2, Published: 2024-01-27 DOI: 10.1101/2024.01.25.577154\nWith the increasing prevalence of antimicrobial-resistant bacterial infections, there is great interest in using lytic bacteriophages (phages) to treat such infections. However, the factors that govern bacteriophage pharmacokinetics in vivo remain poorly understood. Here, we have examined the contribution of neutrophils, the most abundant phagocytes in the body, to the pharmacokinetics of intravenously administered bacteriophage in uninfected mice. A single dose of LPS-5, an antipseudomonal bacteriophage recently used in human clinical trials, was administered intravenously to both wild-type BALB/c and neutropenic ICR mice. Phage concentrations were assessed in peripheral blood and spleen at 0.5, 1, 2, 4, 8, 12, and 24 hours after administration by plaque assay and qPCR. We observed that the phage clearance is only minimally affected by neutropenia. Indeed, the half-life of phages in blood in BALB/c and ICR mice is 3.45 and 3.66 hours, respectively. These data suggest that neutrophil-mediated phagocytosis is not a major determinant of phage clearance. Conversely, we observed a substantial discrepancy in circulating phage levels over time when measured by qPCR versus plaque assay, suggesting that substantial functional inactivation of circulating phages occurs over time. These data indicate that circulating factors, but not neutrophils, inactivate intravenously administered phages.\nNoncaloric monosaccharides induce excessive sprouting angiogenesis in zebrafish via foxo1a-marcksl1a signal\nAuthors: Wang, X.; Zhao, J.; Xu, J.; Li, B.; Liu, X.; Xie, G.; Duan, X.; Liu, D.\nScore: 1.2, Published: 2024-01-22 DOI: 10.1101/2024.01.18.576182\nArtificially sweetened beverages containing noncaloric monosaccharides were suggested as healthier alternatives to sugar-sweetened beverages. Nevertheless, the potential detrimental effects of these noncaloric monosaccharides on blood vessel function remain inadequately understood. Presently, we have established a zebrafish model that exhibits significant excessive angiogenesis induced by high glucose, resembling the hyperangiogenic characteristics observed in proliferative diabetic retinopathy (PDR). Utilizing this model, we observed that glucose and noncaloric monosaccharides could induce excessive formation of blood vessels, especially intersegmental vessels (ISVs). The excessively branched vessels were observed to be formed by ectopic activation of quiescent endothelial cells (ECs) into tip cells. Single-cell transcriptomic sequencing analysis of the endothelial cells in the embryos exposed to high glucose revealed an augmented ratio of capillary ECs, proliferating ECs, and a series of upregulated proangiogenic genes. Further analysis and experiments validated that foxo1a mediated the excessive angiogenesis induced by monosaccharides by down-regulating the expression of marcksl1a. This study has provided new evidence showing the negative effects of noncaloric monosaccharides on the vascular system and the underlying mechanisms.\n",
  "wordCount" : "916",
  "inLanguage": "en",
  "datePublished": "2024-01-28T10:37:59Z",
  "dateModified": "2024-01-28T10:37:59Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/pharmacology-and-toxicology/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      pharmacology and toxicology
    </h1>
    <div class="post-meta">&lt;span&gt;updated on January 28, 2024&lt;/span&gt;

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.01.16.575951">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.01.16.575951" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.01.16.575951">
        <p class="paperTitle">Pharmacogenomics Guided Spaceflight: the intersection between space-flown drugs and space genes</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.01.16.575951" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.01.16.575951" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Nelson, T. M.; Rose, J. K.; Walter, C. E.; Cervantes-Navarro, G. L.; Schmidt, C. M.; Lin, R.; Alexander, E.; Zheng, J. T.; Glicksberg, B. S.; Schmidt, J. C.; Overbey, E.; Rana, B.; Patel, H.; Schmidt, M. A.; Mason, C. E.</p>
        <p class="info">Score: 11.0, Published: 2024-01-20 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.01.16.575951' target='https://doi.org/10.1101/2024.01.16.575951'> 10.1101/2024.01.16.575951</a></p>
        <p class="abstract">Ten years ago, it was predicted that the multi-omics revolution would also revolutionize space pharmacogenomics. Current barriers related to the findable, accessible, interoperable, and reproducible use of space-flown pharmaceutical data have contributed to a lack of progress beyond application of earth-based principles. To directly tackle these challenges, we have produced a novel database of all the drugs flown into space, compiled from publicly available ontological and spaceflight-related datasets, to exemplify analyses for describing significant spaceflight-related targets. By focusing on mechanisms perturbed by spaceflight, we have provided a novel avenue for identifying the most relevant changes within the drug absorption, distribution, metabolism, and excretion pathways. We suggest a set of space genes, by necessity limited to available tissue types, that can be expanded and modified based on future tissue-specific and mechanistic-specific high-throughput assays. In sum, we provide the justification and a definitive starting point for pharmacogenomics guided spaceflight as a foundation of precision medicine, which will enable long-term human habitation of the Moon, Mars, and beyond.

Graphical Abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=147 SRC=&#34;FIGDIR/small/575951v1_ufig1.gif&#34; ALT=&#34;Figure 1&#34;&gt;
View larger version (27K):
org.highwire.dtl.DTLVardef@ac3a07org.highwire.dtl.DTLVardef@115e07corg.highwire.dtl.DTLVardef@1450e46org.highwire.dtl.DTLVardef@ac1757_HPS_FORMAT_FIGEXP  M_FIG C_FIG</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.02.27.530254">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.02.27.530254" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.02.27.530254">
        <p class="paperTitle">Large library docking for cannabinoid-1 receptor agonists with reduced side effects</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.02.27.530254" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.02.27.530254" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Tummino, T. A.; Iliopoulos-Tsoutsouvas, C.; Braz, J. M.; O&#39;Brien, E. S.; Stein, R. M.; Craik, V.; Tran, N. K.; Ganapathy, S.; Liu, F.; Shiimura, Y.; Tong, F.; Ho, T. C.; Radchenko, D. S.; Moroz, Y. S.; Rosado, S. R.; Bhardwaj, K.; Benitez, J.; Liu, Y.; Kandasamy, H.; Normand, C.; Semache, M.; Sabbagh, L.; Glenn, I.; Irwin, J. J.; Kumar, K. K.; Makriyannis, A.; Basbaum, A. I.; Shoichet, B. K.</p>
        <p class="info">Score: 12.2, Published: 2024-01-23 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.02.27.530254' target='https://doi.org/10.1101/2023.02.27.530254'> 10.1101/2023.02.27.530254</a></p>
        <p class="abstract">Large library docking can reveal unexpected chemotypes that complement the structures of biological targets. Seeking new agonists for the cannabinoid-1 receptor (CB1R), we docked 74 million tangible molecules, prioritizing 46 high ranking ones for de novo synthesis and testing. Nine were active by radioligand competition, a 20% hit-rate. Structure-based optimization of one of the most potent of these (Ki = 0.7 {micro}M) led to  4042, a 1.9 nM ligand and a full CB1R agonist. A cryo-EM structure of the purified enantiomer of  4042 ( 1350) in complex with CB1R-Gi1 confirmed its docked pose. The new agonist was strongly analgesic, with generally a 5-10-fold therapeutic window over sedation and catalepsy and no observable conditioned place preference. These findings suggest that new cannabinoid chemotypes may disentangle characteristic cannabinoid side-effects from their analgesia, supporting the further development of cannabinoids as pain therapeutics.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.01.25.577154">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.01.25.577154" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.01.25.577154">
        <p class="paperTitle">The contribution of neutrophils to bacteriophage clearance and pharmacokinetics in vivo</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.01.25.577154" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.01.25.577154" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Echterhof, A.; Dharmaraj, T.; McBride, R.; Berry, J. D.; Hopkins, M.; Selvakumar, H.; Lin, K.-Y.; Chia, L.; Shen, C.-C.; Lioa, W.; Lee, P.; Yeh, T.; Suh, G.; Blankenberg, F. G.; Frymoyer, A.; Bollyky, P.</p>
        <p class="info">Score: 1.2, Published: 2024-01-27 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.01.25.577154' target='https://doi.org/10.1101/2024.01.25.577154'> 10.1101/2024.01.25.577154</a></p>
        <p class="abstract">With the increasing prevalence of antimicrobial-resistant bacterial infections, there is great interest in using lytic bacteriophages (phages) to treat such infections. However, the factors that govern bacteriophage pharmacokinetics in vivo remain poorly understood. Here, we have examined the contribution of neutrophils, the most abundant phagocytes in the body, to the pharmacokinetics of intravenously administered bacteriophage in uninfected mice. A single dose of LPS-5, an antipseudomonal bacteriophage recently used in human clinical trials, was administered intravenously to both wild-type BALB/c and neutropenic ICR mice. Phage concentrations were assessed in peripheral blood and spleen at 0.5, 1, 2, 4, 8, 12, and 24 hours after administration by plaque assay and qPCR. We observed that the phage clearance is only minimally affected by neutropenia. Indeed, the half-life of phages in blood in BALB/c and ICR mice is 3.45 and 3.66 hours, respectively. These data suggest that neutrophil-mediated phagocytosis is not a major determinant of phage clearance. Conversely, we observed a substantial discrepancy in circulating phage levels over time when measured by qPCR versus plaque assay, suggesting that substantial functional inactivation of circulating phages occurs over time. These data indicate that circulating factors, but not neutrophils, inactivate intravenously administered phages.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.01.18.576182">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.01.18.576182" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.01.18.576182">
        <p class="paperTitle">Noncaloric monosaccharides induce excessive sprouting angiogenesis in zebrafish via foxo1a-marcksl1a signal</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.01.18.576182" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.01.18.576182" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Wang, X.; Zhao, J.; Xu, J.; Li, B.; Liu, X.; Xie, G.; Duan, X.; Liu, D.</p>
        <p class="info">Score: 1.2, Published: 2024-01-22 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.01.18.576182' target='https://doi.org/10.1101/2024.01.18.576182'> 10.1101/2024.01.18.576182</a></p>
        <p class="abstract">Artificially sweetened beverages containing noncaloric monosaccharides were suggested as healthier alternatives to sugar-sweetened beverages. Nevertheless, the potential detrimental effects of these noncaloric monosaccharides on blood vessel function remain inadequately understood. Presently, we have established a zebrafish model that exhibits significant excessive angiogenesis induced by high glucose, resembling the hyperangiogenic characteristics observed in proliferative diabetic retinopathy (PDR). Utilizing this model, we observed that glucose and noncaloric monosaccharides could induce excessive formation of blood vessels, especially intersegmental vessels (ISVs). The excessively branched vessels were observed to be formed by ectopic activation of quiescent endothelial cells (ECs) into tip cells. Single-cell transcriptomic sequencing analysis of the endothelial cells in the embryos exposed to high glucose revealed an augmented ratio of capillary ECs, proliferating ECs, and a series of upregulated proangiogenic genes. Further analysis and experiments validated that foxo1a mediated the excessive angiogenesis induced by monosaccharides by down-regulating the expression of marcksl1a. This study has provided new evidence showing the negative effects of noncaloric monosaccharides on the vascular system and the underlying mechanisms.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2024 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        Â· Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
